about
HPV-Testing in Follow-up of Patients Treated for CIN2+ LesionsVIN usual type-from the past to the futureE6/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): a promising perspectiveNeurobiological mechanisms of pelvic painProductive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle.A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.Sexual function after fractional microablative CO₂ laser in women with vulvovaginal atrophy.Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment.Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex vivo study.Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma.Cervical Cancer Prevention: New Frontiers of Diagnostic StrategiesHPV-DNA testing for cervical cancer precursors: from evidence to clinical practicePrognostic significance of immunohistochemical phenotypes in patients treated for high-grade cervical intraepithelial neoplasia.Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females.Cervical Intraepithelial Neoplasia (CIN) in pregnancy: the state of the art.5-Hydroxytyrosol inhibits HIV-1 replication in primary cells of the lower and upper female reproductive tract.Spontaneous regression of low-grade cervical intraepithelial lesions is positively improved by topical bovine colostrum preparations (GINEDIE®). A multicentre, observational, italian pilot study.Human papillomavirus viral load expressed as relative light units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS) cytology.Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO.Extralesional detection and load of human papillomavirus DNA: a possible marker of preclinical tumor spread in cervical cancer.CD4+ T cells against human papillomavirus-18 E7 in patients with high-grade cervical lesions associate with the absence of the virus in the cervix.Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.Fractional carbon dioxide laser in recalcitrant vulvar lichen sclerosus.Semi-quantitative HPV viral load in patients with ASC-US cytology: viral load correlates strongly with the presence of CIN, but only weakly with its severity: letter to the editor.High viral load identifies cervical lesions--letter.An alternative approach for the treatment of vaginal atrophyHuman Papillomavirus DNA and Pap Tests"Low-grade positivity" of HPV viral load after atypical squamous cells of undetermined significance (ASC-US) cytology identifies women at low-risk for cervical intraepithelial neoplasia grade 2 and 3Splenic hamartoma in pregnancyCervical Human Papillomavirus in transplanted Italian women: A long-term prospective follow-up studyAn oral componentHuman papillomavirus with co-existing vulvar vestibulitis syndrome and vestibular papillomatosisTopical oxatomide: an alternative approach for the treatment of vulvar lichen sclerosusTopical testosterone in the treatment of vulvar lichen sclerosusDeterminants of Invasive Vulvar Cancer Risk: An Italian Case-Control StudyEvaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women
P50
Q26771420-D77BE1B9-4461-43FE-B5E8-322A0BF24853Q26865303-219F4749-297F-486E-ABF0-04ACE4B42355Q28087374-D0B0299B-F8D2-478F-9ECC-ED017B414788Q33992977-CA9FBBD0-D3BE-4BFA-809A-2C152A52789BQ34127684-68044DB9-61B3-45A5-AEC4-7966AFE4681FQ35113759-0D3C62CE-0870-40C9-8853-5A2567525356Q35353723-EC488F51-AF3B-4FE5-AA08-0AB75CF0180EQ35437729-CF954DD2-CEA7-4D73-995E-38CFB8A4C1B1Q35546747-28F9B78A-B571-48BB-BF38-7516020F2370Q35605623-6D3880F0-D774-4CE7-AFFB-017191DDD3CCQ35773327-7CFA087B-DF76-441B-A45F-90C781ED9760Q36071760-00AB514C-1A76-40ED-8622-D95DEFC38736Q37426794-BC1C5EEE-7463-4BFE-AD65-22BB5FB943BBQ38032608-E35E5C7F-1306-40FC-92F6-8A3F004E75D6Q38202600-EFC95DC6-39C2-4982-932D-990F2985511BQ40295629-0D95548C-E3A6-4BAC-9159-C7D09CD55CAAQ42229064-C5BBE6E8-EA87-4276-8807-4AB9C060AA36Q44345574-5B54BD9D-8152-4F74-9300-C649DEC1AFB0Q44388600-8B3FF135-9223-432A-B6B7-AB9158960FE3Q45174025-271602B3-33A8-4C91-A53A-9E0D9B8E59FEQ45375334-C4F467A4-3209-46FA-8233-73D2D43F35D3Q45736197-1577277A-2919-40E6-B210-0FC9AB2BBFC2Q48197181-55D29C02-1E0A-49C1-AAB5-F4518F438078Q51807262-3D849947-39C0-405D-B0D8-4481477B699FQ51867218-7FF9FD78-4D36-4473-A570-5E6640BE6F76Q57250189-AE196DED-9125-4F73-97A1-C256B9AF0D57Q57250200-91F88A13-703E-43A5-86E8-89AC910D786FQ57250206-597F7605-B7DF-4F1A-AACD-D3692001A155Q57250216-053498E0-1653-4902-B488-73B5F18563FEQ57250218-C9939A10-4EF3-487F-9283-E2D347F8DDEDQ57250219-89AE2CE4-3C5F-4C21-9779-8747A30BBF3EQ57250228-1BAB62C2-7CA8-43FE-9B2A-9D687D63847CQ57250235-C5254961-159B-4E51-83DC-659FAAC6DDEFQ57250240-8EDDC2FB-165E-442F-AA12-1770FD3F10D9Q57250244-95FC22D0-269E-4D8D-A19A-EAAE5C787952Q77326823-C0071122-23EE-416E-832E-702DACB38DF6
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Massimo Origoni
@ast
Massimo Origoni
@en
Massimo Origoni
@es
Massimo Origoni
@nl
Massimo Origoni
@sl
type
label
Massimo Origoni
@ast
Massimo Origoni
@en
Massimo Origoni
@es
Massimo Origoni
@nl
Massimo Origoni
@sl
prefLabel
Massimo Origoni
@ast
Massimo Origoni
@en
Massimo Origoni
@es
Massimo Origoni
@nl
Massimo Origoni
@sl
P106
P1153
6701532432
P21
P31
P496
0000-0001-6690-3606